双侧原发性乳腺癌两癌间隔时间对ER PR HER-2表达一致性及预后的影响

庄新荣 刘红 王彤

庄新荣, 刘红, 王彤. 双侧原发性乳腺癌两癌间隔时间对ER PR HER-2表达一致性及预后的影响[J]. 中国肿瘤临床, 2012, 39(11): 777-780. doi: 10.3969/j.issn.1000-8179.2012.11.006
引用本文: 庄新荣, 刘红, 王彤. 双侧原发性乳腺癌两癌间隔时间对ER PR HER-2表达一致性及预后的影响[J]. 中国肿瘤临床, 2012, 39(11): 777-780. doi: 10.3969/j.issn.1000-8179.2012.11.006
Xinrong ZHUANG, Hong LIU, Tong WANG. Effects of the Time Interval between Bilateral Primary Breast Cancer on the Prognosis and Concordance of Hormone Receptor and Human Epidermal Growth Factor Receptor-2 Expression[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(11): 777-780. doi: 10.3969/j.issn.1000-8179.2012.11.006
Citation: Xinrong ZHUANG, Hong LIU, Tong WANG. Effects of the Time Interval between Bilateral Primary Breast Cancer on the Prognosis and Concordance of Hormone Receptor and Human Epidermal Growth Factor Receptor-2 Expression[J]. CHINESE JOURNAL OF CLINICAL ONCOLOGY, 2012, 39(11): 777-780. doi: 10.3969/j.issn.1000-8179.2012.11.006

双侧原发性乳腺癌两癌间隔时间对ER PR HER-2表达一致性及预后的影响

doi: 10.3969/j.issn.1000-8179.2012.11.006
详细信息
    通讯作者:

    刘红  kathy_liu99@yahoo.com

Effects of the Time Interval between Bilateral Primary Breast Cancer on the Prognosis and Concordance of Hormone Receptor and Human Epidermal Growth Factor Receptor-2 Expression

More Information
  • 摘要:   目的  分析两癌发生间隔时间对双侧原发性乳腺癌雌激素受体(ER)、孕激素受体(PR)及人表皮生长因子受体2(HER-2)表达一致性及预后的影响。  方法  回顾性分析366例双侧原发性乳腺癌(bilateral primarv breast cancer, BPBC)患者的病理资料, 按照两癌发生的间隔时间进行分组, 侧重分析不同组内第一原发癌与第二原发癌ER、PR、HER-2表达的一致性及两癌间隔时间对BPBC预后的影响。  结果  BPBC第一原发癌与第二原发癌的ER、PR、HER-2表达呈正相关, 两癌间隔时间≤12个月的BPBC双侧ER、PR、HER-2表达密切相关(P < 0.05), 而两癌间隔时间 > 12个月的BPBC双侧ER、PR、HER-2表达相关性无统计学意义(P > 0.05)两癌间隔时间≤12个月较 > 12个月发生者远期生存率低, 预后差。  结论  12个月内发生的BPBC两癌在ER、PR、HER-2表达方面具有较高的相似性, 远期生存率较低, 同异时性BPBC以12个月划分更能反映两癌之间的联系及预后。

     

  • 表  1  双侧原发性乳腺癌ER表达的相关性分析  例

    Table  1.   Association of estrogen receptor status between bilateral primary breast cancers

    表  2  双侧原发性乳腺癌PR表达的相关性分析  例

    Table  2.   Association of progesterone receptor status between bilateral primary breast cancers

    表  3  双侧原发性乳腺癌HER-2表达的相关性分析  例

    Table  3.   Association of HER-2 status between bilateral primary breast cancers

    表  4  不同间隔时间双侧原发性乳腺癌的预后分析

    Table  4.   The prognosis of bilateral primary breast cancer patients with different time intervals

  • [1] 吕明丽, 张晟, 刘红, 等. 双侧原发性乳腺癌ER、PR及HER-2表达特征及其与预后的关系[J]. 中华乳腺病杂志(电子版), 2009, 3(1): 19-23.
    [2] Coradini D, Oriana S, Mariani L, et al. Is steroid receptor profile in contralateral breast cancer a marker of independence of the corresponding primary tumour[J]? Eur J Cancer, 1998, 34(6): 825-830.
    [3] Gong SJ, Rha SY, Jeung HC, et al. Bilateral breast cancer: differential diagnosis using histological and biological parameters[J]. Jpn J Clin Oncol, 2007, 37(7): 487-492. doi: 10.1093/jjco/hym056
    [4] Huo D, Melkonian S, Rathouz PJ, et al. Concordance in histological and biological parameters between first and second primary breast cancers[J]. Cancer, 2011, 117(5): 907-915. doi: 10.1002/cncr.25587
    [5] Robbins GF, Berg JW. Bilateral primary breast cancer: a prospective clinicopathological study[J]. Cancer, 1964, 17: 1501-1527.
    [6] 阚秀, 主编. 乳腺癌临床病理学[M]. 北京: 北京医科大学出版社, 1993: 98-102.
    [7] 《乳腺癌HER2检测指南》编写组. 乳腺癌HER2榆测指南[J]. 中华病理学杂志, 2006, 35(10): 631-633. doi: 10.3760/j.issn:0529-5807.2006.10.015
    [8] Kollias J, Pinder SE, Denley HE, et al. Phenotypic similarities in bilateral breast cancer[J]. Breast Cancer Res Treat, 2004, 85(3): 255-261.
    [9] Swain SM, Wilson JW, Mamounas EP, et al. Estrogen receptor status of primary breast cancer is predictive of estrogen receptor status of contralateral breast cancer[J]. J Natl Cancer Inst, 2004, 96(7): 516-523.
    [10] Vuoto HD, Garcia AM, Candas GB, et al. Bilateral breast carcinoma: clinical characteristics and its impact on survival[J]. Breast J, 2010, 16 (6): 625-632. doi: 10.1111/j.1524-4741.2010.00976.x
    [11] 张涛, 张保宁. 双侧原发性乳腺癌临床与预后分析[J]. 中华肿瘤杂志, 2004.26(12): 55-57. doi: 10.1111/j.1524-4741.2010.00976.x
    [12] Fisher ER, Fisher B, Sass R, et al. Pathologic findings from the National Surgical Adjuvant Breast Project(Protocol No. 4). XI. Bilateral breast cancer[J]. Cancer, 1984, 54(12): 3002-3011. doi: 10.1002/1097-0142(19841215)54:12<3002::AID-CNCR2820541231>3.0.CO;2-V
    [13] Kheirelseid EA, Jumustafa H, Miller N, et al. Bilateral breast cancer: analysis of incidence, outcome, survival and disease characteristics[J]. Breast Cancer Res Treat, 2011, 126(1): 131-140. doi: 10.1007/s10549-010-1057-y
  • 加载中
表(4)
计量
  • 文章访问数:  23
  • HTML全文浏览量:  17
  • PDF下载量:  0
  • 被引次数: 0
出版历程
  • 收稿日期:  2011-06-23
  • 修回日期:  2012-02-01

目录

    /

    返回文章
    返回